{"id":13590,"date":"2003-11-12T00:00:00","date_gmt":"2003-11-12T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/m002-mtg041\/"},"modified":"2019-03-01T15:03:54","modified_gmt":"2019-03-01T15:03:54","slug":"m002-mtg041","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m002-mtg041\/","title":{"rendered":"The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum"},"content":{"rendered":"

Featured Conference<\/b> <\/p>\n The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum<\/a><\/b>
November 12-14, 2003 \u0095 Renaissance Marriott Hotel \u0095 Washington, DC <\/b> <\/p>\n

Overview<\/b>
The Issue<\/b> <\/p>\n

Over the past few years, the pharmaceutical industry has come under increased scrutiny by the federal and state governments as well as the plaintiff’s bar. The U.S. Government, State Attorney Generals and the FDA have begun to more rigorously enforce the rules and regulations that apply to the pharmaceutical industry. Until recently, the majority of the govern-ment’s enforcement efforts have focused on health care providers. Now pharmaceutical companies are finding themselves under the gun. Pharmaceutical companies are being forced to update their knowledge of existing laws and incorporate them into their business plans as well as create future business plans that comply with the often ambiguous and confusing rules and regulations. Critical issues such as drug pricing, sales and marketing practice, conducting clinical trials and a proposed Medicare prescription drug benefit are many topics that will be discussed at this important congress. <\/p>\n

The Congress<\/b> <\/p>\n

The Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (“the Congress”) has been established as a direct result of the heightened need for corporate compliance programs, increased government scrutiny and new regulations being imposed upon the pharmaceutical industry. It will bring together the nation’s leaders in the pharmaceutical industry. This three-day conference, sponsored by the Pharmaceutical Compliance Forum will take place from November 12th through November 14th at the Renaissance Marriott Hotel in Washington, DC. Pharmaceutical professionals looking for a comprehensive understanding of the current and future compliance laws and regulations and enforcement initiatives affecting the pharmaceutical industry should plan to attend. <\/p>\n

Sponsoring Organizations<\/b> <\/p>\n

The Congress is sponsored by:<\/b>
The Pharmaceutical Compliance Forum (PCF)
The Pharmaceutical Compliance Forum was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled in membership since its founding. The members meet twice a year, for one to two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field. <\/p>\n

Who Should Attend:<\/b> <\/p>\n

Pharmaceutical and Health Care Executives and Board Members
Compliance Executives
Health Plan, Health System and Physician Organization
Medical Directors
Physicians
Pharmacists
Purchasers, including Private Employers and Public Purchasers
Pharmaceutical Manufacturers
Generic Pharmaceutical Manufacturers
Site Management Organizations
Clinical Research Organizations
Pharmacy Benefit Management Companies
Health Plans and Health Insurers
Wholesale, Retail, Mail Order and Internet Pharmacies
Health Care Attorneys and In-house Counsel
Compliance Officers
Privacy Officers
Ethics Officers
Food and Drug Law Attorneys
Pharmaceutical Consultants
Investment Bankers
Venture Capitalists
Health Care Regulators and Policy Makers
Health Services Researchers and Academics<\/p>\n

Extensive Written Materials<\/b> <\/p>\n

The Faculty of the Congress will prepare written materials to accompany their presentations, including copies of presentation overheads, slides and related materials that will be included with the Congress materials. <\/p>\n

The Congress Goals and Objectives<\/b> <\/p>\n

At the conclusion of the Congress, attendees should be able to:<\/p>\n